Functional Neuroproteomics: An Imperative Approach for Unravelling Protein Implicated Complexities of Brain.


Journal

CNS & neurological disorders drug targets
ISSN: 1996-3181
Titre abrégé: CNS Neurol Disord Drug Targets
Pays: United Arab Emirates
ID NLM: 101269155

Informations de publication

Date de publication:
2021
Historique:
received: 29 06 2020
revised: 15 07 2020
accepted: 30 08 2020
pubmed: 4 2 2021
medline: 13 1 2022
entrez: 3 2 2021
Statut: ppublish

Résumé

A proteome is defined as a comprehensive protein set either of an organ or an organism at a given time and under specific physiological conditions. Accordingly, the study of the nervous system's proteomes is called neuroproteomics. In the neuroproteomics process, various pieces of the nervous system are "fragmented" to understand the dynamics of each given sub-proteome in a much better way. Functional proteomics addresses the organisation of proteins into complexes and the formation of organelles from these multiprotein complexes that control various physiological processes. Current functional studies of neuroproteomics mainly talk about the synapse structure and its organisation, the major building site of the neuronal communication channel. The proteomes of synaptic vesicle, presynaptic terminal, and postsynaptic density, have been examined by various proteomics techniques. The objectives of functional neuroproteomics are: to solve the proteome of single neurons or astrocytes grown in cell cultures or from the primary brain cells isolated from tissues under various conditions, to identify the set of proteins that characterize specific pathogenesis, or to determine the group of proteins making up postsynaptic or presynaptic densities. It is usual to solve a particular sub-proteome like the heat-shock response proteome or the proteome responding to inflammation. Post-translational protein modifications alter their functions and interactions. The techniques to detect synapse phosphoproteome are available. However, techniques for the analysis of ubiquitination and sumoylation are under development.

Identifiants

pubmed: 33530918
pii: CNSNDDT-EPUB-113861
doi: 10.2174/1871527320666210202121624
doi:

Substances chimiques

Proteome 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

613-624

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Ibraheem Husain (I)

Department of Pharmacology, MESCO Institute of Pharmacy, Amroha, Uttar Pradesh, India.

Wasim Ahmad (W)

Department of Pharmacy, Mohammed Al-Mana College for Medical Sciences, Dammam 34222, Saudi Arabia.

Abuzer Ali (A)

Department of Pharmacognosy, College of Pharmacy, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.

Laiba Anwar (L)

Department of Pharmacology. School of Pharmaceutical Education & Research, Jamia Hamdard, New-Delhi, India.

Sheikh Md Nuruddin (SM)

Department of Pharmacology. School of Pharmaceutical Education & Research, Jamia Hamdard, New-Delhi, India.

Kamran Ashraf (K)

Faculty of Pharmacy, Universiti Teknologi MARA (UiTM), Cawangan Selangor, Kampus Puncak Alam, 42300 Bandar Puncak Alam, Selangor Darul Ehsan, Malaysia.

Mohammad Amjad Kamal (MA)

King Fahd Medical Research Center, King Abdulaziz University, P. O. Box 80216, Jeddah 21589, Saudi Arabia.

Articles similaires

1.00
Humans Magnetic Resonance Imaging Brain Infant, Newborn Infant, Premature
alpha-Synuclein Humans Animals Mice Lewy Body Disease
Animals Optogenetics Visual Cortex Neurons Mice
West Nile Fever Animals West Nile virus Humans Enteric Nervous System

Classifications MeSH